for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Renalytix PLC (ADR)

RNLX.OQ

Latest Trade

19.80USD

Change

1.79(+9.94%)

Volume

53,902

Today's Range

17.99

 - 

19.82

52 Week Range

9.94

 - 

35.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
18.01
Open
17.99
Volume
53,902
3M AVG Volume
2.11
Today's High
19.82
Today's Low
17.99
52 Week High
35.00
52 Week Low
9.94
Shares Out (MIL)
144.45
Market Cap (MIL)
642.36
Forward P/E
--
Dividend (Yield %)
--

Next Event

Renalytix AI PLC Annual Shareholders Meeting

Latest Developments

More

Renalytix Plc Appoints Ann Berman To Board Of Directors

Renalytix Plc Announces Death Of Co-Founder Barbara Murphy

Renalytix Ai Operating Expense For Qtr Was $8.1 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Renalytix PLC (ADR)

Renalytix plc, formerly Renalytix AI plc, is an artificial intelligence-enabled in vitro diagnostics company. The Company's diagnostic platform, KidneyIntelX, employs artificial intelligence-enabled algorithm that combines data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record (HER) systems, to generate a patient risk score. Its patient risk score enables prediction of progressive kidney function decline in chronic kidney disease (CKD), allowing physicians and healthcare systems to manage the allocation of treatments and clinical resources to patients. KidneyIntelX provides a reportable patient risk score integrated with specific guideline-driven clinical recommendations designed to manage patient treatment and compliance outcomes. The KidneyIntelX risk score is tied to specific clinical guideline recommendations developed by the healthcare system, health insurance providers or practice groups.

Industry

Software & Programming

Contact Info

Avon Hse, 19 Stanwell Road

CF64 2EZ

United Kingdom

+44.20.79338780

https://renalytixai.com/

Key Stats

2.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2021(E)

0.0K
EPS (USD)

2021(E)

-0.350
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
7.46
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
1.51
LT Debt To Equity (MRQ)
0.40
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up